If a new drug isn't useful it doesn't matter if the manufacturer has exclusive rights to it.
If people are buying/being prescribed drugs that don't improve their health that's a different problem that won't be solved by changing intellectual property law.
If people are buying/being prescribed drugs that don't improve their health that's a different problem that won't be solved by changing intellectual property law.